ANGELA BANZ: Open Payments
NPI 1285151662 · OGDEN, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$298 in 33 payments from 8 companies in 2025. Trend: 2023 $727 · 2024 $151 · 2025 $298
Food & beverage: $298
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $140 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $45 |
| Ardelyx, Inc. | 2 | $31 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $28 |
| Biocon Biologics Inc | 1 | $20 |
| Madrigal Pharmaceuticals | 1 | $16 |
| Janssen Biotech, Inc. | 1 | $16 |
| Phathom Pharmaceuticals, Inc. | 1 | $3 |
Products named: RINVOQ, ENTYVIO, IBSRELA, SKYRIZI, XIFAXAN, Yesintek, CREON, REZDIFFRA.
Industry payments across UT — which companies pay providers there.
